SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
170look at all that nice downside cushion.scaram(o)uche-1/10/2005
169ArQule Announces Additional Milestone Payments From Wyeth Monday January 10, 7:0nigel bates-1/10/2005
168ARQL presenting at H&Q (JP Morgan) next Wednesday afternoon, 3:30 p.m., Paciscaram(o)uche-1/5/2005
167Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):212-9. Susceptibility of cancerscaram(o)uche-1/5/2005
166>> and the stock soars just after he's sold his last share << dscaram(o)uche-1/5/2005
165well.... if not reflecting anything of substance re. business plan, at least tscaram(o)uche-1/5/2005
164Very nice pointer. Looks for real or, at least, continuing.keokalani'nui-1/3/2005
163I have no idea why, but ARQL had a nice move out of congestion on above average tom pope-1/2/2005
162>>Enrollment of First Patient in Phase 1b Combination Trial Of ARQ 501 andtuck-12/14/2004
161ArQule Announces Enrollment of First Patient in Phase 1b Combination Trial Of ARmopgcw-12/7/2004
160From FBR Report on ASH: p38 inhibitor, SCIO-469 stops growth of myeloma cells inmopgcw-11/30/2004
159[NQO1 Polymorphisms & NQO1-directed antitumor quinones for therapy] >>tuck-11/30/2004
158[LIMD1 binds pRB and represses E2F-driven transcription] >>Published onlituck-11/12/2004
157Leg: ARQL :Pipeline Flying Under the Radar Screen; Upgrading to Buy Rating Octomopgcw-10/31/2004
156Legg Mason Ups ArQule To Buy From Hold DOW JONES NEWSWIRES October 29, 2004 8:4Doc Bones-10/29/2004
155>> ArQule's most advanced preclinical programs, 550RP (second generatiscaram(o)uche-10/28/2004
154ArQule Announces Third Quarter Earnings Thursday October 28, 7:01 am ET Confermopgcw-10/28/2004
153"... the growing strength and stature of the ArQule Biomedical Institute&quformer_pgs-10/13/2004
152ArQule Announces the Discovery of Oral B-RAF Kinase Inhibitors for Oncology and nigel bates-10/13/2004
151Chiang Li's presentation, Oct. 5th, in pdf format: media.corporate-ir.netmh00034-10/9/2004
150Agreed that it was a strange presentation. I was left with a more favourable imIan@SI-10/6/2004
149Ian, The way I heard it, the partial responder received one of the lowest doseskeokalani'nui-10/6/2004
148That certainly is an alternative explanation, although dose escalation over six Biomaven-10/5/2004
147The impression that I got was that there was no response until an effective dosaIan@SI-10/5/2004
146<i>The PR didn't start responding beyond stable disease until the 8 moBiomaven-10/5/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News